The J&J lawsuit in 2026 is reaching a turning point. After years of legal battles, failed bankruptcy strategies, and billions in proposed payouts, Johnson & Johnson’s talcum powder litigation is closer to resolution than ever before.
Tens of thousands of plaintiffs say J&J’s talc products caused ovarian cancer and mesothelioma. The company has offered roughly $8 billion through a settlement trust to resolve these claims.
If you used J&J baby powder or other talc products, this article breaks down everything you need to know. You’ll learn who qualifies, how much you could receive, the key 2026 deadlines, and exactly how to file a claim.
One fact worth knowing: more than 100,000 claims have been filed against J&J over talc products. The outcome of this case could set a precedent for corporate accountability for years to come.
What Is the J&J Lawsuit About
The J&J lawsuit is a massive legal action against Johnson & Johnson alleging that its talcum powder products contained asbestos and caused cancer in users. Plaintiffs include women diagnosed with ovarian cancer and individuals who developed mesothelioma after long-term exposure to J&J’s talc-based products.
The first lawsuits were filed over a decade ago. Since then, juries have returned some of the largest verdicts in U.S. product liability history against the company.
J&J has consistently denied that its talc products are dangerous. The company has pointed to internal testing and regulatory reviews to support its position.
But thousands of plaintiffs tell a different story. Their claims are backed by independent lab findings, expert testimony, and documents obtained through discovery showing that J&J knew about potential asbestos contamination for decades.
| Detail | Info |
|---|---|
| Defendant | Johnson & Johnson |
| Products at Issue | Baby Powder, Shower to Shower, other talc cosmetics |
| Allegations | Asbestos contamination causing cancer |
| Number of Claims | Over 100,000 |
| Cancers Alleged | Ovarian cancer, mesothelioma |
| First Lawsuits Filed | Early 2010s |
The case isn’t just about talc. It’s become a test case for whether corporations can use bankruptcy subsidiaries to limit liability in mass tort litigation.
J&J Lawsuit Update for 2026
The most significant J&J lawsuit update for 2026 is that Johnson & Johnson’s third attempt at a prepackaged bankruptcy settlement plan is moving through the courts. After two failed bankruptcy filings through its subsidiary LTL Management, J&J restructured its approach under a new entity called Red River Talc LLC.
In January 2025, a federal bankruptcy judge in Houston approved the plan. But appeals followed quickly. By mid-2025, the case was being reviewed by higher courts.
Heading into 2026, several things are happening at once:
- The Third Circuit Court of Appeals is expected to issue a ruling on the plan’s legality
- Claimants who voted in favor of the settlement are awaiting confirmation
- J&J has signaled it may increase the total settlement fund if needed to secure approval
The 2026 landscape looks like a make-or-break year. If the appellate court upholds the plan, payouts could begin flowing. If it doesn’t, the litigation could restart in full force across individual courtrooms.
Key date to watch: A ruling from the Third Circuit is anticipated in the first half of 2026.
J&J Lawsuit Settlement Explained
The J&J lawsuit settlement is a proposed resolution that would create a trust fund to compensate all talc-related cancer claimants. Under the most recent plan, J&J has committed approximately $8 billion over 25 years to fund this trust.
Here’s how it works. J&J’s subsidiary, Red River Talc, filed for Chapter 11 bankruptcy. Through the bankruptcy process, the company proposed a plan that would halt all individual lawsuits and channel claims into a single trust.
Claimants vote on the plan. If enough vote “yes,” the court can confirm it and begin distributing funds.
The settlement would cover:
- Current diagnosed claimants with ovarian cancer
- Mesothelioma claimants
- Future claimants diagnosed after the plan is confirmed
- Wrongful death claims filed by families of deceased users
The plan requires 75% approval from voting claimants. During the 2024/2025 voting process, J&J reported that a strong majority voted in favor, though some plaintiff attorneys contested the vote count and process.
If confirmed, this would be one of the largest mass tort settlements in American history. Think of it like the tobacco settlement of the 1990s, but compressed into a single company and a single product line.
Key Takeaway: The J&J lawsuit centers on talc products allegedly contaminated with asbestos, and the proposed $8 billion settlement plan is the closest the case has come to a broad resolution.
The J&J Talcum Powder Lawsuit Story
The J&J talcum powder lawsuit started with a handful of women who suspected their cancer was linked to a product they’d used their entire lives. Baby powder. Something their mothers and grandmothers trusted. The idea that it could cause cancer seemed impossible at first.
But internal J&J documents revealed a different picture. Company memos from the 1970s and 1980s showed that J&J’s own scientists raised concerns about asbestos fibers in talc supplies. Some of these documents suggested the company chose not to disclose findings to regulators or consumers.
The first major verdict came in 2016 when a St. Louis jury awarded $72 million to the family of a woman who died of ovarian cancer. More verdicts followed, including a landmark $4.69 billion judgment in 2018 involving 22 women.
| Year | Verdict/Event | Amount |
|---|---|---|
| 2016 | First major jury verdict (St. Louis) | $72 million |
| 2018 | 22-plaintiff verdict (St. Louis) | $4.69 billion |
| 2021 | LTL Management bankruptcy filing | N/A |
| 2023 | Second bankruptcy attempt dismissed | N/A |
| 2024 | Red River Talc LLC bankruptcy filed | N/A |
| 2025 | Bankruptcy plan approved by judge | $8 billion proposed |
J&J stopped selling talc-based baby powder in the U.S. and Canada in 2020. By 2023, the company switched globally to a cornstarch-based formula.
J&J Lawsuit Payout Per Person
The J&J lawsuit payout per person depends on the type of cancer diagnosed, the severity, and the evidence linking it to talc use. Not every claimant will receive the same amount. The settlement plan uses a tiered system to distribute funds.
Based on the proposed trust distribution:
| Claim Category | Estimated Payout Range |
|---|---|
| Mesothelioma (current) | $75,000 to $750,000+ |
| Ovarian cancer (current, severe) | $50,000 to $500,000+ |
| Ovarian cancer (current, less severe) | $10,000 to $100,000 |
| Future cancer diagnosis | Varies by trust funds available |
| Wrongful death claims | $25,000 to $500,000+ |
These are estimated ranges. The actual amounts will depend on:
- Total number of approved claims
- Available trust funds at time of distribution
- Individual claim scoring based on a points matrix
- Length and frequency of talc product use
- Medical documentation strength
Some high-value mesothelioma claims could exceed $1 million based on prior jury verdicts. But the settlement trust payouts will almost certainly be lower than what juries have awarded in individual trials. That’s the tradeoff: guaranteed money through the trust vs. the risk of going to trial and possibly getting nothing.
J&J Lawsuit: Who Qualifies in 2026
To qualify for the J&J lawsuit in 2026, you generally need to meet two requirements. First, you must have used a J&J talc-based product. Second, you must have been diagnosed with a qualifying medical condition.
Qualifying conditions include:
- Ovarian cancer (epithelial types, particularly serous)
- Mesothelioma (peritoneal or pleural)
- Other cancers potentially linked to asbestos exposure from talc
Products that qualify:
- Johnson’s Baby Powder (talc-based formula)
- Shower to Shower body powder
- Other J&J talc-containing cosmetic products
You don’t need to have purchased the product yourself. If someone in your household used it and you were exposed, you may still qualify.
Family members of someone who died from a talc-related cancer can file a wrongful death claim on their behalf.
| Eligibility Factor | Requirement |
|---|---|
| Product Used | J&J talc-based powder product |
| Diagnosis | Ovarian cancer, mesothelioma, or related cancer |
| Proof of Use | Purchase records, testimony, or sworn statements |
| Time Period | No strict cutoff, but long-term use strengthens claims |
| Status | Living claimants and wrongful death claims both eligible |
There’s no age cutoff. Both current and future diagnosed claimants are included in the proposed plan.
Key Takeaway: Payouts vary widely based on cancer type and evidence, and you must show both product use and a qualifying cancer diagnosis to be eligible for compensation.
The J&J Baby Powder Lawsuit Connection
The J&J baby powder lawsuit is the most recognizable piece of this litigation. Johnson’s Baby Powder was the company’s signature product for over a century. It was marketed to mothers, families, and women as safe for daily use on the most sensitive skin.
For decades, millions of women used baby powder for personal hygiene, particularly in the genital area. That’s the connection that matters legally. Perineal use of talc-based baby powder has been linked in studies to an increased risk of ovarian cancer.
J&J marketed baby powder aggressively to communities of color, targeting Black and Hispanic women through advertising campaigns. This fact has added a dimension of environmental justice and racial equity to the litigation.
The company pulled its talc baby powder from North American shelves in May 2020, citing declining sales and what it called “misinformation.” It continued selling the talc version internationally until 2023 before switching entirely to cornstarch.
- Baby powder was J&J’s most iconic consumer product
- Marketed specifically for perineal use in women
- Targeted advertising toward Black and Hispanic communities
- Removed from U.S. market in 2020
- Globally switched to cornstarch formula in 2023
Even though the product is no longer sold in its talc form, the lawsuits cover decades of past use. If you used J&J baby powder at any point and later developed ovarian cancer, you may have a claim.
J&J Talc Settlement Amount Breakdown
The J&J talc settlement amount under the current plan totals approximately $8 billion to be paid over 25 years into a trust. This number has increased from earlier proposals. J&J initially offered around $6.5 billion before raising the figure to secure more votes.
Here’s how the money is structured:
| Component | Amount |
|---|---|
| Total Trust Funding | ~$8 billion |
| Payment Period | 25 years |
| Source | Johnson & Johnson and Kenvue |
| Distribution Method | Claims trust with tiered payouts |
| Initial Distributions | Expected to begin within 12 to 18 months of plan confirmation |
The trust will be managed by an independent trustee. Claimants submit their claims and supporting evidence. Each claim is scored using a point system that factors in:
- Type of cancer
- Duration of product use
- Age at diagnosis
- Medical expenses
- Lost income
- Pain and suffering
Higher-scoring claims get larger payouts. The system is designed to be more predictable than trial outcomes but less generous than the biggest jury verdicts.
J&J’s consumer health spin-off company, Kenvue, is also contributing to the settlement fund. Kenvue was created in 2023 when J&J separated its consumer products division from its pharmaceutical and medical device businesses.
J&J Lawsuit Deadline for 2026
The J&J lawsuit deadline in 2026 depends on which stage the settlement plan reaches. If the Third Circuit upholds the bankruptcy plan, specific claim filing deadlines will be announced shortly after.
Based on the current trajectory, here are the anticipated 2026 deadlines:
| Milestone | Expected Timing |
|---|---|
| Third Circuit ruling on appeal | Q1 or Q2 2026 |
| Claim filing window opens (if plan confirmed) | Mid-2026 |
| Initial claim submission deadline | Late 2026 or early 2027 |
| First trust distributions | 12 to 18 months after confirmation |
If you already filed a claim or joined the litigation, your case should be automatically included in the trust. New claimants will have a window to submit claims once the plan is confirmed.
Don’t wait until the last minute. Gathering medical records, product use evidence, and supporting documentation takes time. Start collecting now even if the exact filing deadline hasn’t been set.
If the plan is rejected by the appeals court, individual lawsuits will resume. In that scenario, statute of limitations rules in your state become the relevant deadline. Many states have specific time limits for filing personal injury or product liability claims after a cancer diagnosis.
Key Takeaway: The Third Circuit ruling expected in early to mid-2026 will determine whether the settlement plan moves forward, and claimants should prepare their documentation now regardless of the outcome.
How to File a J&J Lawsuit Claim
Filing a J&J lawsuit claim involves several steps, and the exact process depends on whether the settlement plan is confirmed or litigation continues through individual lawsuits.
If the settlement trust is confirmed, here’s the general process:
- Register your claim with the talc trust administrator
- Complete the official claim form (more on this below)
- Submit medical records confirming your cancer diagnosis
- Provide evidence of J&J talc product use
- Submit any additional supporting documentation
- Wait for claim review and scoring
- Receive a payout determination
- Accept or dispute the amount offered
If the settlement plan is rejected:
- You can file an individual lawsuit in state or federal court
- Your attorney will handle court filings and discovery
- Cases may go to trial or settle individually
Most claimants work with a personal injury attorney who handles these filings on a contingency fee basis. That means you pay nothing upfront. The attorney takes a percentage of your settlement or verdict, typically between 25% and 40%.
You don’t need to have a lawyer to file a claim with the trust. But given the complexity of the scoring system and the stakes involved, legal representation is strongly recommended.
J&J Lawsuit and Ovarian Cancer
The J&J lawsuit ovarian cancer connection is the core of most talc claims. Thousands of women allege that regular perineal use of J&J talcum powder caused their ovarian cancer. Scientific studies have found a statistical association between genital talc use and ovarian cancer risk.
The proposed biological pathway works like this. Talc particles, when applied to the genital area, can travel through the reproductive tract. Those particles reach the ovaries and cause chronic inflammation. Over time, that inflammation may trigger cancerous cell growth.
Key studies supporting this link:
- A 2016 study in the journal Epidemiology found a 33% increased risk of ovarian cancer among women who used talc regularly
- The Women’s Health Initiative study involving over 60,000 women found a modest but statistically significant association
- The International Agency for Research on Cancer (IARC) classified talc used in the genital area as “possibly carcinogenic to humans” (Group 2B)
| Study/Source | Finding |
|---|---|
| Epidemiology (2016) | 33% increased ovarian cancer risk |
| Women’s Health Initiative | Statistically significant association |
| IARC Classification | Group 2B: possibly carcinogenic |
| Harvard Nurses’ Health Study | Elevated risk with frequent, long-term use |
J&J disputes this science. The company says that the largest studies show no causal link and that its products were regularly tested and found to be asbestos-free.
Juries have disagreed. Multiple trials have resulted in verdicts exceeding hundreds of millions of dollars for ovarian cancer plaintiffs.
J&J Mesothelioma Lawsuit Claims
J&J mesothelioma lawsuit claims represent a smaller but financially significant portion of the talc litigation. Mesothelioma is a rare and aggressive cancer caused almost exclusively by asbestos exposure. Claimants allege that asbestos fibers contaminated J&J’s talc supply.
The connection between talc and asbestos is geological. Talc and asbestos are minerals that naturally occur together in the earth. When talc is mined, asbestos fibers can contaminate the supply if not properly filtered or tested.
Mesothelioma claims tend to receive higher payouts because:
- Mesothelioma is directly caused by asbestos, making causation easier to prove
- The disease has a very poor prognosis, often fatal within 12 to 21 months
- Juries and trust administrators recognize the severity
| Mesothelioma Claim Detail | Info |
|---|---|
| Cause | Asbestos fibers in talc products |
| Average Prognosis | 12 to 21 months survival |
| Estimated Trust Payout | $75,000 to $750,000+ |
| Prior Jury Verdicts | Up to $120 million in individual cases |
| Proof Required | Diagnosis + evidence of J&J talc exposure |
Testing by independent labs, including a 2018 Reuters investigation, found asbestos traces in J&J baby powder samples spanning decades. J&J’s own internal documents referenced asbestos concerns as early as the 1970s.
The FDA also found asbestos in J&J baby powder during 2019 and 2020 testing, leading to a product recall of specific lots.
Key Takeaway: Ovarian cancer and mesothelioma claims form the two pillars of the talc litigation, with mesothelioma cases generally commanding higher payouts due to the direct asbestos connection and the disease’s deadly nature.
The J&J Bankruptcy Settlement Plan
The J&J bankruptcy settlement plan has been one of the most controversial legal strategies in modern mass tort history. Rather than facing each lawsuit individually, J&J created a subsidiary, transferred all talc liabilities to it, and then filed that subsidiary for bankruptcy.
This strategy is known as the “Texas Two-Step” because it involves a divisional merger under Texas business law. The idea is to separate profitable assets from legal liabilities. Critics call it an abuse of the bankruptcy system designed to shortchange victims.
Here’s the timeline of bankruptcy attempts:
| Attempt | Entity | Year | Outcome |
|---|---|---|---|
| First | LTL Management | 2021 | Dismissed by Third Circuit (2023) |
| Second | LTL Management | 2023 | Dismissed by Third Circuit (2023) |
| Third | Red River Talc LLC | 2024 | Approved by bankruptcy judge (2025); on appeal |
The Third Circuit dismissed the first two attempts, ruling that LTL Management was not in sufficient “financial distress” to justify bankruptcy protection. For the third attempt, J&J restructured the deal to address these legal concerns.
The current plan through Red River Talc includes the $8 billion trust, a higher voting threshold achieved through claimant solicitation, and additional protections for future claimants.
If the appeals court rejects this third attempt, J&J faces the prospect of tens of thousands of individual trials. That reality is what gives the company motivation to keep raising the settlement amount.
Is the J&J Lawsuit a Class Action
The J&J class action lawsuit label is a common misconception. Technically, the J&J talc litigation is not a class action. It’s a mass tort organized as a multidistrict litigation (MDL).
Here’s the difference:
| Feature | Class Action | Mass Tort/MDL |
|---|---|---|
| Individual claims | No; one claim represents all | Yes; each person has their own claim |
| Payout | Same for all class members | Varies based on individual circumstances |
| Opt-in/Opt-out | Usually opt-out | Must actively file |
| Case management | Single case | Consolidated for pre-trial, individual for trial |
| Attorney relationship | Lead counsel represents class | Each claimant has own attorney |
The J&J talc cases are consolidated under MDL 2738 in the U.S. District Court for the District of New Jersey. This consolidation means pre-trial activities like discovery and expert testimony are handled together. But each case retains its individual facts.
Why does this matter to you? Because in a mass tort, your specific circumstances determine your payout. Your medical records, your product usage history, your diagnosis, all of it factors into your individual claim value. You’re not just one face in a crowd.
The settlement trust, if confirmed, functions somewhat like a class action resolution. But legally, it’s structured through bankruptcy, not class certification.
J&J Lawsuit Evidence You Need
The J&J lawsuit evidence you’ll need depends on whether you’re filing a trust claim or pursuing an individual lawsuit. In both cases, stronger evidence means a stronger claim and a higher potential payout.
Essential evidence includes:
- Medical records confirming a diagnosis of ovarian cancer or mesothelioma
- Pathology reports specifying the type and stage of cancer
- Product purchase records such as receipts, store loyalty card data, or credit card statements
- Personal testimony describing how often, how long, and where you used J&J talc products
- Witness statements from family members or friends who can confirm your product use
- Expert medical opinions linking your cancer to talc or asbestos exposure
Helpful but not required:
- Photos of the product in your home
- Advertising materials you received from J&J
- Employment records if occupational exposure is a factor
| Evidence Type | Importance Level | Notes |
|---|---|---|
| Cancer diagnosis records | Critical | Must specify cancer type and date |
| Product use history | Critical | Duration, frequency, and method of use |
| Purchase receipts | Helpful | Strengthens claim but sworn testimony can substitute |
| Witness testimony | Helpful | Family/friend confirmation of product use |
| Pathology reports | Critical | Stage and type of cancer affect payout tier |
Don’t panic if you don’t have receipts from 20 years ago. Most people don’t. Sworn declarations about your usage patterns are accepted as evidence. Your memory of using the product, corroborated by a family member, carries weight.
Key Takeaway: You don’t need perfect records to file a J&J talc claim, but medical documentation of your cancer diagnosis and a credible account of product use are both essential to receive compensation.
J&J Lawsuit Timeline for 2026
The J&J lawsuit timeline for 2026 is packed with potential turning points. This year could see the final resolution of the settlement plan or a return to courtroom battles across the country.
Projected 2026 timeline:
| Time Period | Expected Event |
|---|---|
| Q1 2026 | Third Circuit hears oral arguments or issues ruling on Red River Talc bankruptcy appeal |
| Q1 to Q2 2026 | Possible Supreme Court petition if either side loses at Third Circuit |
| Q2 2026 | If plan upheld: trust finalization and claim processing begins |
| Q3 2026 | Claim filing window expected to open for new claimants |
| Q3 to Q4 2026 | Initial claim reviews and scoring begin |
| Late 2026 to early 2027 | First trust distributions to highest-priority claims (mesothelioma, terminal cases) |
If the plan is rejected:
- Individual lawsuits resume across state and federal courts
- Bellwether trials could be scheduled within 6 to 9 months
- J&J may attempt a fourth restructured settlement offer
- State-level statute of limitations becomes the controlling deadline
Think of 2026 as the fork in the road. One path leads to a structured, guaranteed payout through the trust. The other leads back to the unpredictability of individual trials, where some people win big and others walk away with nothing.
Either way, claimants should be actively preparing their documentation and maintaining contact with their attorneys throughout the year.
How to Complete the J&J Lawsuit Claim Form
The J&J lawsuit claim form is the official document you submit to the settlement trust to request compensation. While the exact form may be updated once the plan is confirmed, here’s what to expect based on similar mass tort claim forms and the proposed trust structure.
Typical sections of the claim form:
- Personal information: Full name, address, date of birth, Social Security number
- Product identification: Which J&J talc product you used
- Usage details: How often, how long, and where on your body you applied the product
- Medical information: Type of cancer, date of diagnosis, treating physicians
- Treatment history: Surgeries, chemotherapy, radiation, and current status
- Supporting documents: Attach medical records, pathology reports, and any purchase evidence
- Attorney information: If represented, your lawyer’s contact details
- Signature and declaration: Sworn statement that the information is truthful
Tips for completing the form:
- Be as specific as possible about product usage dates and frequency
- Attach every piece of medical documentation you have
- If you lack purchase receipts, include a detailed sworn statement
- Have your attorney review the form before submission
- Keep copies of everything you submit
- Submit before the deadline, not on the deadline
The form will likely be available online through the trust administrator’s website once the plan is confirmed. Paper versions may be available by request.
The J&J Talc Cancer Link: What Science Says
The J&J talc cancer link has been debated by scientists, regulators, and corporate interests for decades. The question has two parts: does talc itself cause cancer, and does asbestos contamination in talc cause cancer?
On the asbestos question, the science is clear. Asbestos causes cancer. That’s not debated. Asbestos causes mesothelioma and contributes to other cancers. If J&J’s talc contained asbestos, any resulting cancer claims rest on solid scientific ground.
On the talc-only question, the picture is more nuanced. Here’s where the major scientific bodies stand:
| Organization | Position on Genital Talc and Cancer |
|---|---|
| IARC (WHO) | Group 2B: possibly carcinogenic to humans |
| National Toxicology Program | Not formally classified |
| American Cancer Society | Acknowledges association; calls for more research |
| FDA | Found asbestos in J&J samples; increased testing requirements |
| J&J’s Position | Denies causal link; cites studies showing no association |
The strongest epidemiological evidence comes from cohort studies and meta-analyses showing a 20% to 33% increased risk of ovarian cancer among regular perineal talc users. That’s a modest increase in relative terms, but applied across millions of users, it translates to thousands of potential cancer cases.
J&J points to the Nurses’ Health Study and the Women’s Health Initiative as evidence against causation. But critics note that these studies have limitations in how they measured talc exposure.
The scientific debate may never reach complete consensus. But in the legal system, the standard isn’t scientific certainty. It’s preponderance of the evidence, meaning more likely than not. Multiple juries have found that standard met.
Key Takeaway: The science supporting a talc-cancer connection is strong enough to win in courtrooms, and the asbestos contamination evidence makes mesothelioma claims particularly powerful.
Frequently Asked Questions
How much money will I get from the J&J lawsuit in 2026?
Most claimants can expect between $10,000 and $500,000, depending on their cancer type and claim strength.
Mesothelioma claims typically receive the highest payouts, potentially exceeding $750,000.
The exact amount depends on the trust’s scoring matrix, your medical evidence, and your product use history.
What is the deadline to file a J&J talc lawsuit claim?
A specific deadline has not been set as of early 2026 because the settlement plan is still under appeal.
Once the plan is confirmed, a claim filing window will be announced, likely with a deadline in late 2026 or early 2027.
Start gathering your medical records and product use evidence now so you’re ready when the window opens.
Does J&J baby powder really cause cancer?
Multiple scientific studies have found a statistical link between perineal talc use and ovarian cancer.
The IARC classifies genital talc use as “possibly carcinogenic,” and independent testing found asbestos in J&J baby powder samples.
Juries in multiple trials have ruled that J&J’s talc products contributed to plaintiffs’ cancer diagnoses.
Can I still file a J&J lawsuit if I was never diagnosed with cancer?
Currently, only individuals diagnosed with ovarian cancer, mesothelioma, or related cancers qualify for the settlement trust.
If you used J&J talc products but have not been diagnosed with cancer, you do not have a claim at this time.
The settlement plan includes provisions for “future claimants” who may be diagnosed later.
What happens if the J&J settlement plan gets rejected again?
If the Third Circuit rejects the Red River Talc bankruptcy plan, individual lawsuits will resume across state and federal courts.
J&J would face the possibility of tens of thousands of separate trials, which is exactly what the company has been trying to avoid.
The company may propose a new settlement structure or increased funding to gain approval in a future attempt.
The J&J talc lawsuit in 2026 is at a crossroads. Whether the settlement trust moves forward or the litigation returns to courtrooms, your ability to collect compensation depends on being prepared.
Gather your medical records. Document your history with J&J talc products. Stay in contact with your attorney or find one if you don’t have representation.
This is not the time to sit back and wait. The decisions being made right now will determine how much money reaches the people who were harmed.
